Skip to NavigationSkip to content

News

GlaxoSmithKline and Bayer have agreed to pay $344 million to settle charges of defrauding the US Government healthcare system.
Health service to pilot US system to tackle admissions
Abbott Laboratories has launched its new rheumatoid arthritis treatment Humira in Europe claiming its biggest ever product could eventually become...
Prexige, the new challenger to the established Cox-II drugs from Novartis has been dealt a serious blow after the FDA issued it with a non-approvable...
Fred Hassan has outlined his plans to turn round the fortunes of struggling Schering-Plough after being installed as the company new chief executive.
Sales revenues at Roche have been dealt a serious blow by currency fluctuations in the first quarter, with a strong Swiss franc undercutting sales...
Novartis' atypical antipsychotic Clozaril could lead to a reduction in suicide rate among patients suffering from schizophrenia, according to a new...
The UK patent system is damaging scientific research and creating a old rush mentality according to the Royal Society.
The prospects for the troubled Anglo-American giant GlaxoSmithKline may be changing after a storm of patent expiry threats, senior executive...
The project to decode the human genome has been completed two years ahead of schedule, but scientists have warned against premature hopes for medical...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches